|
EP3513802B1
(en)
|
2012-10-26 |
2023-11-29 |
Vrije Universiteit Brussel |
Vector for liver-directed gene therapy of hemophilia and methods and use thereof
|
|
EP2920319B1
(en)
|
2012-11-16 |
2020-02-19 |
Poseida Therapeutics, Inc. |
Site-specific enzymes and methods of use
|
|
EP3080274B1
(en)
|
2013-12-09 |
2020-06-03 |
Sangamo Therapeutics, Inc. |
Methods and compositions for genome engineering
|
|
JP2017518082A
(ja)
*
|
2014-06-17 |
2017-07-06 |
ポセイダ セラピューティクス， インコーポレイテッド |
ゲノム中の特異的遺伝子座にタンパク質を指向させるための方法およびその使用
|
|
AU2015301598B2
(en)
*
|
2014-08-13 |
2020-07-16 |
Liron Elkouby |
An improved expression cassette for packaging and expression of variant Factor VIII for the treatment of hemostasis disorders
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
AU2016215124B2
(en)
*
|
2015-02-06 |
2020-08-06 |
The University Of North Carolina At Chapel Hill |
Optimized human clotting Factor VIII gene expression cassettes and their use
|
|
JP6879486B2
(ja)
*
|
2015-03-17 |
2021-06-02 |
フリーイェ・ユニヴェルシテイト・ブリュッセルＶｒｉｊｅ Ｕｎｉｖｅｒｓｉｅｉｔ Ｂｒｕｓｓｅｌ |
Ｆｖｉｉｉおよびｆｉｘ用の最適化された肝臓特異的発現系
|
|
TWI707951B
(zh)
|
2015-04-08 |
2020-10-21 |
美商健臻公司 |
過大腺相關載體之製造
|
|
EP3626274B1
(en)
*
|
2015-04-16 |
2025-01-22 |
Emory University |
Recombinant promoters and vectors for protein expression in liver and use thereof
|
|
GB201508026D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
US11103597B2
(en)
|
2015-05-14 |
2021-08-31 |
St. Jude Children's Research Hospital, Inc. |
Nucleic acid molecules containing spacers outside ITR
|
|
EP3929286A1
(en)
|
2015-06-17 |
2021-12-29 |
Poseida Therapeutics, Inc. |
Compositions and methods for directing proteins to specific loci in the genome
|
|
BR112018006074A2
(pt)
*
|
2015-09-24 |
2018-10-09 |
Biomarin Pharm Inc |
vetores de fator viii de vírus adeno-associado, partículas virais associadas e formulações terapêuticas compreendendo as mesmas
|
|
US11230720B2
(en)
|
2015-10-14 |
2022-01-25 |
Audentes Therapeutics, Inc. |
Nucleic acid molecules containing spacers and methods of use thereof
|
|
KR102766526B1
(ko)
*
|
2015-10-28 |
2025-02-13 |
상가모 테라퓨틱스, 인코포레이티드 |
간-특이적 작제물인, 인자 viii 발현 카세트 및 이의 사용 방법
|
|
EP3374388A1
(en)
|
2015-11-13 |
2018-09-19 |
Baxalta Incorporated |
Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
|
|
SG11201804070XA
(en)
|
2015-11-13 |
2018-06-28 |
Baxalta Inc |
Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
|
|
KR20180118659A
(ko)
*
|
2016-02-01 |
2018-10-31 |
바이오버라티브 테라퓨틱스 인크. |
최적화된 viii 인자 유전자
|
|
WO2017180857A1
(en)
*
|
2016-04-15 |
2017-10-19 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treating hemophilia a
|
|
WO2017180861A1
(en)
|
2016-04-15 |
2017-10-19 |
The Trustees Of The University Of Pennsulvania |
Gene therapy for treating hemophilia b
|
|
RU2770006C2
(ru)
|
2016-05-16 |
2022-04-14 |
Такеда Фармасьютикал Компани Лимитед |
Антитела к фактору ix padua
|
|
WO2018049009A2
(en)
|
2016-09-07 |
2018-03-15 |
Sangamo Therapeutics, Inc. |
Modulation of liver genes
|
|
US11541131B2
(en)
|
2017-03-10 |
2023-01-03 |
Genethon |
Treatment of glycogen storage disease III
|
|
WO2018178067A1
(en)
|
2017-03-27 |
2018-10-04 |
Vrije Universiteit Brussel |
Diaphragm-specific nucleic acid regulatory elements and methods and use thereof
|
|
US11633504B2
(en)
|
2017-05-09 |
2023-04-25 |
Emory University |
Nucleic acids encoding clotting factor variants and their use
|
|
KR102386890B1
(ko)
|
2017-05-22 |
2022-04-15 |
다케다 야쿠힌 고교 가부시키가이샤 |
B형 혈우병 유전자 요법을 위한 증가된 발현을 가지는 재조합 fix 변이체를 암호화하는 바이러스 벡터
|
|
DK3652326T3
(da)
*
|
2017-07-10 |
2024-10-28 |
Uniqure Ip Bv |
Midler og fremgangsmåder til AAV-genterapi i mennesker
|
|
US10610606B2
(en)
|
2018-02-01 |
2020-04-07 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
|
|
US20190256867A1
(en)
|
2018-02-01 |
2019-08-22 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
|
|
CN112041437A
(zh)
|
2018-02-19 |
2020-12-04 |
同源药物公司 |
用于恢复f8基因功能的腺相关病毒组合物和其使用方法
|
|
AU2019306194A1
(en)
|
2018-07-16 |
2021-02-04 |
Baxalta GmbH |
Gene therapy of hemophilia A using viral vectors encoding recombinant FVIII variants with increased expression
|
|
JP7684212B2
(ja)
|
2018-08-03 |
2025-05-27 |
サンガモ セラピューティクス， インコーポレイテッド |
第ｖｉｉｉ因子の発現による改善された臨床パラメーター
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
WO2020084162A1
(en)
|
2018-10-26 |
2020-04-30 |
Vrije Universiteit Brussel |
Liver-specific nucleic acid regulatory elements and methods and use thereof
|
|
WO2020084161A1
(en)
|
2018-10-26 |
2020-04-30 |
Vrije Universiteit Brussel |
New tools for improving gene therapy and use thereof
|
|
TWI851647B
(zh)
|
2019-01-16 |
2024-08-11 |
日商武田藥品工業股份有限公司 |
用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體
|
|
WO2020160303A1
(en)
|
2019-02-01 |
2020-08-06 |
Baxalta Incorporated |
Gene therapy of hemophilia b using viral vectors encoding recombinant fix variants with increased expression
|
|
CN115176022A
(zh)
|
2019-10-23 |
2022-10-11 |
夏尔人类遗传性治疗公司 |
用于遗传性血管性水肿的基于腺相关病毒载体的基因疗法
|
|
US20230023826A1
(en)
|
2019-12-12 |
2023-01-26 |
Takeda Pharmaceutical Company Limited |
Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expression
|
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
|
|
CA3191743A1
(en)
*
|
2020-09-16 |
2022-03-24 |
Generation Bio Co. |
Non-viral dna vectors and uses thereof for expressing fviii therapeutics
|
|
CN111926041B
(zh)
*
|
2020-10-16 |
2020-12-25 |
广州吉妮欧生物科技有限公司 |
一种SARS-CoV-2假病毒小鼠体内包装系统及其制备方法
|
|
WO2022187671A1
(en)
*
|
2021-03-04 |
2022-09-09 |
Poseida Therapeutics, Inc. |
Compositions and methods for the treatment of hemophilia
|
|
US20250152748A1
(en)
*
|
2021-03-25 |
2025-05-15 |
Johns Hopkins University |
Hydrodynamic gene delivery
|
|
JP2024527252A
(ja)
|
2021-06-14 |
2024-07-24 |
武田薬品工業株式会社 |
発現の増加した組み換えｆｖｉｉｉバリアントをコードするウイルスベクターを用いた、血友病ａの遺伝子療法
|
|
AR126660A1
(es)
|
2021-07-28 |
2023-11-01 |
Univ Brussel Vrije |
Mejorando la eficacia de la terapia génica dirigida a músculos
|
|
WO2023135273A2
(en)
|
2022-01-14 |
2023-07-20 |
Anjarium Biosciences Ag |
Compositions of dna molecules encoding factor viii, methods of making thereof, and methods of use thereof
|
|
WO2024074143A1
(en)
*
|
2022-10-08 |
2024-04-11 |
Lingyi Biotech Co., Ltd. |
Construct for enhancing gene expression
|
|
WO2025008774A1
(en)
|
2023-07-05 |
2025-01-09 |
Takeda Pharmaceutical Company Limited |
Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
|
|
WO2025226943A1
(en)
|
2024-04-25 |
2025-10-30 |
Masonic Medical Research Laboratory |
Polynucleotide for hepatocyte expression of vestigial like protein 4 and method of use thereof
|